Esperion Therapeutics, Daiichi Sankyo Europe Ink $125 Mln Amendment To Their Collaboration

RTTNews | Před 609 dny
Esperion Therapeutics, Daiichi Sankyo Europe Ink $125 Mln Amendment To Their Collaboration

(RTTNews) - Esperion Therapeutics, Inc. (ESPR) and Daiichi Sankyo Europe GmbH or DSE, the European arm of Japanese pharmaceutical company Daiichi Sankyo Co., Ltd. (DSKYF.PK), announced Wednesday a $125 million amendment to their collaboration, which includes an amicable resolution to their commercial dispute and certain other adjustments to enhance the long-term value of their products.

DSE has agreed to pay Esperion $100 million in mid-January ahead of an anticipated Type II(a) variation approval by the European Medicines Agency (EMA) for NILEMDO (bempedoic acid) Tablet and NUSTENDI (bempedoic acid and ezetimibe) Tablet.

DSE will make an additional $25 million payment to Esperion in the calendar quarter immediately following EMA's decision on the pending application.

The legal action pending in the United States District Court for the Southern District of New York will be dismissed.

Since 2019, Esperion and DSE have worked together to bring bempedoic acid to the eligible patient population and unlock its potential for cardiovascular risk reduction. The partnership continues to grow, with DSE recently gaining approvals for bempedoic acid in the Netherlands, Slovakia, and Spain.

read more
Merck, Daiichi Sankyo Say FDA Grants Priority Review In U.S. For Patritumab Deruxtecan

Merck, Daiichi Sankyo Say FDA Grants Priority Review In U.S. For Patritumab Deruxtecan

Merck & Co. Inc. (MRK) and Japan's Daiichi Sankyo Co. Ltd. (DSKYF.PK) announced Friday that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the Biologics License Application (BLA) for patritumab deruxtecan (HER3-DXd) for the treatment of adult patients with locally advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC) previously treated with two or more systemic therapies.
RTTNews | Před 621 dny
Australia Trade Data Due On Thursday

Australia Trade Data Due On Thursday

Australia will on Thursday release August numbers for imports, exports and trade balance, highlighting a modest day for Asia-Pacific economic activity. In July, imports were down 3.1 percent on month and exports rose 6.0 percent for a trade surplus of A$5.365 billion.
RTTNews | Před 1 h 2 min
Swiss Market Closes On Bright Note

Swiss Market Closes On Bright Note

The Switzerland market closed on a bright note on Wednesday after holding firm right through the day's trading session thanks to sustained buying at several counters from across various sectors.
RTTNews | Před 5 h 0 min
Consumer Staples, Materials Stocks Rise As TSX Hits New Record High

Consumer Staples, Materials Stocks Rise As TSX Hits New Record High

The Canadian market is up in positive territory a little past noon on Wednesday, thanks to strong gains in consumer staples, materials and technology sectors. Energy and healthcare stocks are weak, while shares from rest of the sectors are turning in a mixed performance.
RTTNews | Před 6 h 17 min
U.S. Job Openings Fall To Ten-Month Low In July

U.S. Job Openings Fall To Ten-Month Low In July

Job openings in the U.S. fell to their lowest level in ten months in July, according to a report released by the Labor Department on Wednesday. The Labor Department said job openings dipped to 7.181 million in July after tumbling to a downwardly revised 7.357 million in June.
RTTNews | Před 7 h 30 min
U.S. Factory Orders Slump Roughly In Line With Estimates In July

U.S. Factory Orders Slump Roughly In Line With Estimates In July

A report released by the Commerce Department on Wednesday showed an extended slump by new orders for U.S. manufactured goods in the month of July. The Commerce Department said factory orders fell by 1.3 percent in July after plunging by 4.8 percent in June. Economists had expected factory orders to decrease by 1.4 percent.
RTTNews | Před 8 h 36 min